About Hôtel-Dieu de France Hospital
أوتيل ديو دو فرانس هو أحد المراكز الطبية اللبنانية الرائدة الثلاثة، وأقدم مستشفى فرنسي نشط في بيروت، لبنان. يقع في شارع الفريد النقاش، بيروت.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Hôtel-Dieu de France Hospital
During the past decade, Hôtel-Dieu de France Hospital conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 11 clinical trials were completed, i.e. on
average, 26.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 10 clinical trials were completed. i.e. 83.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hôtel-Dieu de France Hospital" #1 sponsor was "St Joseph University, Beirut, Lebanon" with 11 trials, followed by "Saint-Joseph University" with 10 trials
sponsored, "Hotel Dieu de France Hospital" with 4 trials sponsored, "Daiichi Sankyo, Inc." with 3 trials sponsored and "Octapharma"
with 3 trials sponsored. Other sponsors include 18 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôtel-Dieu de France Hospital"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Hotel Dieu de France Hospital" with 1 trials as a collaborator, "Instituto Grifols, S.A." with 1 trials as a collaborator and "LEVENTON" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Hôtel-Dieu de France Hospital
According to Clinical.Site data, the most researched conditions in "Hôtel-Dieu de France Hospital" are
"Afibrinogenemia, Congenital" (2 trials), "Atrial Fibrillation" (2 trials), "Botulinum Toxin" (2 trials), "Congenital Afibrinogenemia" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Hôtel-Dieu de France Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Hôtel-Dieu de France Hospital
Most popular intervention types in "Hôtel-Dieu de France Hospital" are "Drug" (42 trials), "Procedure" (8 trials), "Biological" (5 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Dexmedetomidine" (2 trials), "Edoxaban" (2 trials), "Etrasimod" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hôtel-Dieu de France Hospital
The vast majority of trials in "Hôtel-Dieu de France Hospital" are
45 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Hôtel-Dieu de France Hospital
Currently, there are NaN active trials in "Hôtel-Dieu de France Hospital".
undefined are not yet recruiting,
1 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 34 completed trials in Hôtel-Dieu de France Hospital,
1 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hôtel-Dieu de France Hospital, 2 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 15 trials, and there were
also 5 trials that are defined as “Not Applicable".